BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33070078)

  • 1. The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines.
    Robinson WJ; Taylor AE; Lauga-Cami S; Weaver GW; Arroo RRJ; Kaiser M; Gul S; Kuzikov M; Ellinger B; Singh K; Schirmeister T; Botana A; Eurtivong C; Bhambra AS
    Eur J Med Chem; 2021 Jan; 209():112871. PubMed ID: 33070078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of diphenyl ether benzyl amines against Human African Trypanosomiasis.
    Hagen JP; Darner G; Anderson S; Higgins K; Leas DA; Mitra A; Mashinson V; Wol T; Vera-Esquivel C; Belter B; Cal M; Kaiser M; Wallick A; Warner RC; Davis PH
    Bioorg Chem; 2020 Apr; 97():103590. PubMed ID: 32179269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria.
    Di Chio C; Starvaggi J; Totaro N; Previti S; Natale B; Cosconati S; Bogacz M; Schirmeister T; Legac J; Rosenthal PJ; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 4-[4-(4-methylpiperazin-1-yl)phenyl]-6-arylpyrimidine derivatives and their antitrypanosomal activities against T.brucei.
    Taylor AE; Hering M; Elsegood MRJ; Teat SJ; Weaver GW; Arroo RRJ; Kaiser M; Maeser P; Bhambra AS
    Bioorg Med Chem Lett; 2024 May; 109():129825. PubMed ID: 38823730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
    Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
    J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro Anti-trypanosomal and Cytotoxicity Evaluation of 3-methyl-3,4-dihydroquinazolin-2(1H)-one Derivatives.
    Jesumoroti OJ; Beteck RM; Legoabe LJ
    Drug Res (Stuttg); 2021 Jul; 71(6):335-340. PubMed ID: 33535253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness.
    Kaiser M; Bray MA; Cal M; Bourdin Trunz B; Torreele E; Brun R
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5602-8. PubMed ID: 21911566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
    Jones AJ; Kaiser M; Avery VM
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of tetrahydroisoquinoline derivatives against Trypanosoma brucei rhodesiense.
    Cullen DR; Gallagher A; Duncan CL; Pengon J; Rattanajak R; Chaplin J; Gunosewoyo H; Kamchonwongpaisan S; Payne A; Mocerino M
    Eur J Med Chem; 2021 Dec; 226():113861. PubMed ID: 34624822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bistacrines as potential antitrypanosomal agents.
    Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
    Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitrypanosomal Chloronitrobenzamides.
    Carrillo AK; Kadayat TM; Hwang JY; Chen Y; Zhu F; Holbrook G; Gillingwater K; Connelly MC; Yang L; Kaiser M; Guy RK
    J Med Chem; 2024 Mar; 67(5):3437-3447. PubMed ID: 38363074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter.
    Gilbert IH
    Parasitology; 2014 Jan; 141(1):28-36. PubMed ID: 23931634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of an orally active nitrothiophene-based antitrypanosomal agent.
    Ajayi O; Metibemu DS; Crown O; Adeyinka OS; Kaiser M; Shoji N; Silva M; Rodriguez A; Ogungbe IV
    Eur J Med Chem; 2024 Jan; 263():115954. PubMed ID: 37984297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
    Nwodo NJ; Brun R; Osadebe PO
    J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antitrypanosomal tetranotriterpenoids from Azadirachta indica.
    Githua M; Hassanali A; Keriko J; Murilla G; Ndungu M; Nyagah G
    Afr J Tradit Complement Altern Med; 2010 Apr; 7(3):207-13. PubMed ID: 21461147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antitrypanosomal activitiy of two microbial metabolites, KS-505a and alazopeptin.
    Ishiyama A; Otoguro K; Namatame M; Nishihara A; Furusawa T; Masuma R; Shiomi K; Takahashi Y; Ichimura M; Yamada H; Omura S
    J Antibiot (Tokyo); 2008 Oct; 61(10):627-32. PubMed ID: 19168977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis.
    Ettari R; Previti S; Maiorana S; Amendola G; Wagner A; Cosconati S; Schirmeister T; Hellmich UA; Zappalà M
    J Med Chem; 2019 Dec; 62(23):10617-10629. PubMed ID: 31714776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.
    Previti S; Ettari R; Di Chio C; Ravichandran R; Bogacz M; Hellmich UA; Schirmeister T; Cosconati S; Zappalà M
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.